advertisement
 

  Back to Press Releases Animas Receives FDA Clearance for Software System

Animas Corporation Receives FDA 510(k) Clearance
For its Diabetes Management Software System

Frazer, PA - June 19, 2003 - Animas Corporation, a manufacturer of insulin infusion pumps and other products for patients with insulin-requiring diabetes, announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance to market ezManager Plus.

ezManager Plus, the first software system of its kind to receive FDA 510(k) clearance, differs from other available systems with its comprehensive food database, carbohydrate calculator, and ability to accept download information from both the Animas IR 1000 insulin pump and a variety of blood glucose meters.

This software system, with both a Palm-OS and desktop module, is designed to help people better manage their diabetes and help reduce the time healthcare professionals need to spend helping patients manage diabetes. With this intuitive program, patients can:

Commenting on the FDA clearance, Dr. Katherine Crothall, Animas' CEO said, "Managing diabetes properly is very time-intensive for patients and their healthcare teams. Patients need to adjust their insulin intake based upon the carbohydrate content of their meal and current blood glucose readings, necessitating patients thumbing through food databases and performing multi-step computations. Many patients simply make wild guesses. ezManager Plus removes much of the guesswork and significantly simplifies the time-intensive computations.

"We are also committed to developing tools that reduce the strain on the already over-burdened healthcare system. The reports available from ezManager Plus give patients and the healthcare team a comprehensive view of important parameters of diabetes management and allow healthcare professionals to focus more efficiently on developing treatment plans for their patients," Dr. Crothall explains.

###

About Animas Corporation: Animas, a leading maker of insulin infusion pumps and related products, is dedicated to improving diabetes management and making insulin pump therapy easier for patients with insulin-requiring diabetes and healthcare professionals through product innovation, exemplary customer support and superior customer education. For more information on Animas, visit www.animascorp.com or call Animas Corporation at 877-937-7867.

For Immediate Release
Contact: Mindy Cooper
Animas Corporation
610-644-8990, ext. 1157
mindy.cooper@animascorp.com

[ View the Press Release PDF Format ]



                 
  Home Return to Top

Last Updated: Wednesday November 05, 2014 21:27:23
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.